Interesting... I hold both RAP and this stock, in large quantities, well over 1m. In truth it is chalk and cheese, RAP is disruptive with no competitors, GMV has many competitors in most of its area of expertise. Yes it has revenue, but from where I sit it will be dwarfed by RAP's potential in both Respiratory and sleep apnea.
I still hold some hope with this company but my sail is flapping in the wind.
GMV Price at posting:
8.1¢ Sentiment: Buy Disclosure: Held
